Preparation and physicochemical evaluation of a new tacrolimus tablet formulation for sublingual administration

被引:15
作者
Srinarong, Parinda [1 ]
Pham, Bao T. [1 ]
Holen, Maru [2 ]
van der Plas, Afke [3 ]
Schellekens, Reinout C. A. [2 ]
Hinrichs, Wouter L. J. [1 ]
Frijlink, Henderik W. [1 ]
机构
[1] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands
[2] Univ Med Ctr Groningen, Dept Clin & Hosp Pharm, NL-9713 AV Groningen, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands
关键词
Tacrolimus; disintegration; dissolution; amorphous; solid dispersions; freeze drying; inulin; polyvinylpyrrolidone; SOLID DISPERSIONS; ORGAN-TRANSPLANTATION; DISSOLUTION BEHAVIOR; IMMUNOSUPPRESSANT; PHARMACOKINETICS; BIOAVAILABILITY; PERFORMANCE; SODIUM; FK506;
D O I
10.3109/03639045.2011.613075
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to develop a new fast-disintegrating tablet formulation containing 1 mg tacrolimus for sublingual application. First, solid dispersions containing tacrolimus (2.5%, 5% and 10% w/w) incorporated in Ac-Di-Sol (R) and carriers (inulin 1.8 kDa and 4 kDa, and polyvinylpyrrolidone (PVP) K30) were prepared by freeze drying. Subsequently, a tablet formulation composed of a mixture of the solid dispersions, Ac-Di-Sol (R), mannitol, Avicel (R) PH-101 and sodium stearyl fumarate was optimized concerning drug load in the solid dispersions and the type of carrier. Tablet weight was kept constant at 75 mg by adjusting the amount of Avicel (R) PH-101. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) results indicated the absence of the drug in the crystalline state, which was confirmed by the scanning electron microscopy (SEM). These results suggest that tacrolimus incorporated in all of the solid dispersions was fully amorphous. Dissolution of the tablets containing solid dispersions with a low drug load highly depends on the type of carrier and increased in the order: PVP K30 < inulin 4 kDa < inulin 1.8 kDa. Solid dispersions with a drug load of 10% w/w incorporated in the carriers yielded optimal formulations. In addition, the physicochemical characteristics and the dissolution behavior of the tablet formulation containing inulin 1.8 kDa-based solid dispersions with a drug load of 10% w/w did not change after storage at 20 degrees C/45% RH for 6 months indicating excellent storage stability.
引用
收藏
页码:490 / 500
页数:11
相关论文
共 28 条
[1]   Hollow filler-binders as excipients for direct compaction [J].
Bolhuis, GK ;
Eissens, AC ;
Adrichem, TP ;
Wesselingh, JA ;
Frijlink, HW .
PHARMACEUTICAL RESEARCH, 2003, 20 (03) :515-518
[2]  
Buhler V., 2005, Polyvinylpyrrolidone Excipients for Pharmaceuticals
[3]   Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated [J].
de Waard, H. ;
Hinrichs, W. L. J. ;
Visser, M. R. ;
Bologna, C. ;
Frijlink, H. W. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 349 (1-2) :66-73
[4]   DRUG ABSORPTION BY SUBLINGUAL AND RECTAL ROUTES [J].
DEBOER, AG ;
DELEEDE, LGJ ;
BREIMER, DD .
BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (01) :69-82
[5]   PHARMACOKINETICS OF TACROLIMUS IN LIVER-TRANSPLANT PATIENTS [J].
JUSKO, WJ ;
PIEKOSZEWSKI, W ;
KLINTMALM, GB ;
SHAEFER, MS ;
HEBERT, MF ;
PIERGIES, AA ;
LEE, CC ;
SCHECHTER, P ;
MEKKI, QA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :281-290
[6]   PHARMACOKINETICS OF SULFISOXAZOLE SOLID DISPERSIONS IN RABBITS [J].
KASSEM, MA ;
ELRIDY, MS ;
KHAIRY, LM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (07) :1171-1196
[7]   Tertiary-Butanol: A toxicological review [J].
McGregor, Douglas .
CRITICAL REVIEWS IN TOXICOLOGY, 2010, 40 (08) :697-727
[8]   Spray dried excipient base: A novel technique for the formulation of orally disintegrating tablets [J].
Mishra, DN ;
Bindal, M ;
Singh, SK ;
Kumar, SGV .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (01) :99-102
[9]  
Moyano MA, 2006, J AOAC INT, V89, P1547
[10]   KINETIC-ANALYSIS OF MOLECULAR INTERCONVERSION OF IMMUNOSUPPRESSANT FK506 BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
NISHIKAWA, T ;
HASUMI, H ;
SUZUKI, S ;
KUBO, H ;
OHTANI, H .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1785-1789